John Robert Vane
Vane, John Robert, 1927-2004
![Sudoc [ABES], France](/viaf/images/flags/SUDOC.png "Sudoc [ABES], France")
Vane, John R.
Vane, John R., 1927-
Vane, John R., 1927-2004
ויין, ג'ון ר.
Vane, John Robert, 1927-
Vane, John R. (John Robert), 1927-
VIAF ID: 110349841 (Personal)
Permalink: http://viaf.org/viaf/110349841
Preferred Forms
-
100 0 _
‡a
John Robert Vane
-
200 _ |
‡a
Vane
‡b
John Robert
‡f
1927-2004
-
100 1 _ ‡a Vane, John R
-
100 1 _ ‡a Vane, John R.
-
100 1 _ ‡a Vane, John R.
-
100 1 _ ‡a Vane, John R.
-
100 1 _
‡a
Vane, John R.
-
100 1 _
‡a
Vane, John R.
-
100 1 _ ‡a Vane, John R. ‡d (1927- ).
-
100 1 _
‡a
Vane, John R.
‡d
1927-2004
-
100 1 _ ‡a Vane, John R. ‡q (John Robert), ‡d 1927-
-
100 1 _ ‡a Vane, John R., ‡d 1927-
-
100 1 _ ‡a Vane, John R., ‡d 1927-2004
-
100 1 _ ‡a Vane, John Robert ‡d (1927-2004)
-
100 1 _
‡a
Vane, John Robert
‡d
1927-2004
-
100 1 _ ‡a Vane, John Robert, ‡d 1927-
-
100 1 _
‡a
Vane, John Robert,
‡d
1927-2004
-
100 1 _ ‡a Vane, John Robert, ‡d 1927-2004
-
100 1 _ ‡a ויין, ג'ון ר.
4xx's: Alternate Name Forms (53)
5xx's: Related Names (2)
- 551 _ _
‡a
Farnborough
‡g
London
- 551 _ _
‡a
Tardebigge
Works
| Title | Sources |
|---|---|
| Adv. clin. pharmacol. (New York N.Y.) |
|
| Aspirin and other salicylates |
|
| Asthma : basic mechanisms and therapeutic perspectives |
|
| Ciba Foundation Symposium jointly with Committee for Symposia on Drug Action, on Adrenergic Mechanisms. [Papers and discussions] |
|
| Eicosanoids, aspirin and asthma |
|
| The endothelial cell in health and disease |
|
| Endothelin IV : proceedings of the fourth international conference on endothelin, held at the William Harvey Rersearch Institute, London, U.K. April 23-26, 1995 |
|
| Endothelium as a regulator of vascular tone and growth |
|
| Endotoxin and production of prostaglandins by the isolated rabbit jejunum : Influence of indomethacin. |
|
| Factors influencing the turnover of prostaglandin synthetase |
|
| Gastric secretion induced by histamine |
|
| Half-lives of Peptides and Amines in the Circulation |
|
| History of aspirin and its mechanism of action. |
|
| Hormones Released into the Circulation When the Urinary Bladder of the Anaesthetized Dog is Distended |
|
| Human neutrophils and mononuclear cells inhibit platelet aggregation by releasing a nitric oxide-like factor |
|
| Identification of an enzyme in platelet microsomes which generates thromboxane A2 from prostaglandin endoperoxides |
|
| Identification of endothelin 1 and big endothelin 1 in secretory vesicles isolated from bovine aortic endothelial cells |
|
| Imidazole: a selective inhibitor of thromboxane synthetase |
|
| Immediate release of a nitric oxide-like factor from bovine aortic endothelial cells by Escherichia coli lipopolysaccharide |
|
| Improved non-steroid anti-inflammatory drugs COX-2 enzyme inhibitors : proceedings of a conference held on October 10-11, 1995, at Regent's College, London |
|
| Incomplete inhibition of the pressor effects of endothelin-1 and related peptides in the anaesthetized rat with BQ-123 provides evidence for more than one vasoconstrictor receptor |
|
| Increased Angiotensin Formation in Response to Carotid Occlusion in the Dog |
|
| Induction of cyclo-oxygenase-2 by cytokines in human pulmonary epithelial cells: regulation by dexamethasone |
|
| Induction of nitric oxide synthase activity by toxic shock syndrome toxin 1 in a macrophage-monocyte cell line |
|
| Inflammation |
|
| Inhibition by L-glutamine of the release of endothelium-derived relaxing factor from cultured endothelial cells |
|
| Inhibition by spermine of the induction of nitric oxide synthase in J774.2 macrophages: requirement of a serum factor |
|
| Inhibition of converting enzyme of the renin-angiotensin system in kidneys and hindlegs of dogs. |
|
| Inhibition of cyclo-oxygenase and lipoxygenase |
|
| Inhibition of nitric oxide synthesis reduces the hypotension induced by bacterial lipopolysaccharides in the rat in vivo |
|
| Inhibition of platelet-derived mitogen release by nitric oxide (EDRF). |
|
| Inhibition of prostaglandin biosynthesis |
|
| Interaction of the platelets and the vessel walls |
|
| Jubileusz 30-lecia Centrum Medycyny Doświadczalnej i Klinicznej PAN, Warszawa, 13-16 października 1997 r. |
|
| Metabolic functions of the lung |
|
| Najważniejsze: obudzić się! |
|
| A new perfusion method |
|
| New targets in inflammation : inhibitors of COX-2 or adhesion molecules : proceedings of a conference held on April 15-16, 1996, in New Orleans, USA, supported by an educational grant from Boehringer Ingelheim |
|
| Nihon Enshō Gakkai. Winter Seminar (1983 : Tokyo, Japan). Pers. in prostaglandin res., 1983: |
|
| A patient's guide to coronary bypass surgery and its aftermath : advice from a survivor |
|
| Phrmacologic properties of the new nitric oxide donor ITF 296 |
|
| Prostacyclin |
|
| Prostaglandin synthetase inhibitors : their effects on physiological functions and pathological states ; sponsored jointly by the Royal Society of Medicine Foundation, inc. of New York and the Royal Society of Medicine of London, held November 28-30, 1973 at the Rockefeller University, New York City |
|
| Prostaglandins and the mechanism of analgesia produced by aspirin-like drugs. |
|
| The pulmonary circulation and acute lung injury |
|
| The release of catecholamines by shocks and stimuli paired with shocks |
|
| Selective COX-2 inhibitors : pharmacology, clinical effects, and therapeutic potential : proceedings of a conference held on March 20-21, 1997, in Cannes, France |
|
| A sensitive method for the assay of 5-hydroxytryptamine |
|
| Sir John Robert Vane (1927-2004) |
|
| The technique of superfusion |
|
| Therapeutic applications of prostaglandins |
|
| Tryptamine Receptors in the Central Nervous System: Effects of Anæsthetics |
|
| Tryptamines and spinal cord reflexes in cats |
|
| The use of isolated organs for detecting active substances in the circulating blood. 1964 |
|
| The use of oxyhaemoglobin to explore the events underlying inhibition of platelet aggregation induced by NO or NO-donors |
|
| Use of the endothelin antagonists BQ-123 and PD 142893 to reveal three endothelin receptors mediating smooth muscle contraction and the release of EDRF. |
|
| Vascular actinos of arachidonic acid and its metabolites in perfused mesenteric and femoral beds of the dog |
|
| Vascular hyporeactivity to vasoconstrictor agents and hemodynamic decompensation in hemorrhagic shock is mediated by nitric oxide |
|
| Vasoconstriction in the rat kidney induced by endothelin-1 is blocked by PD 145065. |
|
